Sprague-Dawley rats were exposed to 0,26, or 2600 ppm lead as lead acetate in drinking water for 76 weeks. At 28 weeks of lead exposure, a portion of each group was exposed simultaneously to 6.36 g/kg ethyl urea (EU) and 2.0 g/kg sodium nitrite (NaNOJ for a duration of 20 weeks, and then continued an additional 28 weeks on standard diet free of EU and NaN02. The animals were observed for incidence, latency, and distribution of tumors. ,Rats exposed to 2600 ppm lead alone had 81% renal tumors, while rats given 2600 ppm lead in combination with EU/NaN02 had a 50% incidence. Renal tumors did not occur in the EU/NaN02 only or EU/NaN02-26 ppm lead groups. The major tumor type found in EU/NaNOr-exposed rats was lymphosarcoma. lead did not appear to be syncarcinogenic to the activity of ethylnitrosourea, the carcinogen formed by oral exposure to EU and NaN02. The lead-induced renal neoplasms were histologically similar to those which occur spontaneously in man and, therefore, may serve as an animal model to study human disease.
Many leafy vegetables concentrate nitrate under favorable conditions of soil and water. Tobacco contains ni tra te-origina t ed volatile nitrosamines in the smoke (3, 16) .
Syncarcinogenic activity and promoting factors frequently influence carcinogenic processes. Man in certain situations may be exposed simultaneously to lead and the precursors of ethylnitrosourea (ENU) via environmental sources or consumption of contaminated food and water. The purpose of this investigation was to determine if 1) longterm oral administration of lead was carcinogenic in rats; 2) lead, ethyl urea, and sodium nitrite were co-carcinogenic; and 3) lead affected the incidence, latency, distribution, or type of tumors induced by a known carcinogen, ethylnitrosourea.
METHODS
Fifty-six weanling male Sprague-Dawley rats were obtained from the Laboratory Animal Resources Center, Oregon State University. They were divided into five groups (Table I) . Group I(10 animals) served as untreated controls. Group I1 (10 animals) received only ethyl urea (EU) and sodium nitrite (NaNO,), Group 111 (10 animals) was given EU/NaN02 plus 26 ppm lead as lead acetate in deionized water ad libitum, Group IV (10 animals) was given EU/NaNO, plus 2600 ppm lead in water, and Group V (16 animals) was given only 2600 ppm lead in water. All rats were housed individually in hanging wire cages and fed standard Oregon State University rodent chow ad libitum. The animals were weighed weekly.
Lead was administered to respective groups for a total of 76 weeks. Twenty-eight weeks after initiation of lead exposure, animals to receive EU/NaNO, were placed on diets containing 6.36 g/kg EU and 2.0 g/kg NaNO,. The EU/NaN02 diet was fed for 5 additional months after which time the EU/NaNO, diet was removed and replaced with regular Oregon State University chow. During the entire period of EU/NaNO, administration (from 28 to 48 weeks), lead exposure was continued. Animals were observed daily for neoplasm and other diseases. Upon death or when moribund, complete necropsies were performed. Tissues for histologic examination were fixed in 10% buffered formalin, processed by standard techniques, and stained with hematoxylin and eosin. Sections from liver, kidneys, spleen, lungs, heart, brain, spinal cord, cranial and peripheral nerves, testes, intestine, stomach, urinary bladder, lymph nodes, and adrenal glands were examined. Tissues and lesions were evaluated histologically to determine type of lesions, per cent of rats with lesions, and degree of alteration from normal pathology. Rats surviving to 76 weeks of age were terminated and necropsied.
RESULTS
EU/NaN02 and Lead-induced Tumor lncidence. Neoplasms were produced in all animals given EU/NaNO, or lead but none were observed in the untreated animals. A variety of neoplasms developed in rats administered EU/NaNO,, the most common was lymphosarcoma (Table 11 ). Rats given EU/NaNO, Ethyl urea and sodium nitrite were fed in the diet from 28 to 48 weeks of the experiment at dosages of 6.36 g/kg and Lead was given in deionized drinking water for the duration of the experiment (76 weeks). Ethyl urea and sodium nitrate were fed in the diet from 28 to 48 weeks of the experiment at dosages of 6.36 g/kg and Lead was given in deior)ized drinking water for the duration of the experiment (76 weeks). 20 .0 g/kg, respectively; numbers refer to number of animals affected per group.
alone had tumors in lymphoid tissue, intestines, bile duct, stomach, abdomen, and brain. Animals exposed to both EU/NaNOZ and 26 ppm lead had neoplasms similar to those given only EU/NaNOZ. Fifty per cent of the rats given EU/NaNO, and 2600 ppm lead exhibited renal tubular carcinomas which were not observed in the 26 ppm lead or EU/ NaNOZ only groups. The first renal tumor was identified at 54 weeks of age. Lead-induced Tumor Incidence. Thirteen of 16 rats (81%) fed 2600 ppm lead only had renal tubular carcinoma by 76 weeks of exposure. Renal neoplasms in 3 of these rats metastasized. Metastasis were observed in the lungs, adrenal glands, and lymphatics.
Animals receiving 2600 ppm Iead showed clearly the influence of a high dose of lead in the kidney. Many tubules in the cortex were necrotic and often dilated forming cyst-like structures of various size. These tubules frequently contained protein casts. Less frequently, areas containing large nuclei and fibrous connective tissue extended from the capsule to the medulla. Large eosinophilic intranuclear inclusion bodies were numerous in the enlarged epitheIia1 cells of the cortex near the cortical-medullary junction. These lesions were not apparent in the kidneys of the 26 ppm lead-exposed animals.
Morphology of Lead-induced Tumors. The neoplasms in the kidneys of animals exposed to 2600 ppm lead were usually large circumscribed nodules separated from the adjacent renal tissue (Fig. I) . These neoplasms were microscopically invasive and appeared to showed a high incidence (53%) of kidney tumors that were similar to the renal tumors of animals exposed only to 2600 ppm lead. Lymphosarcoma was the most corr.monly encountered neoplasm in the EU/NaSO, only and EL,'NaNO, + 26 ppm lead groups. In grow by expansion with varying degrees of local invasion. The adjacent renal parenchyma was usually compressed and atrophic.
The renal tumors generally were of either a tubular or solid pattern. The tubular pattern resembled compressed renal tubules which consisted of well-differentiated to randomly oriented tubules separated by a delicate fibrovascular stroma (Fig. 2 ). Occasionally. a large round neoplasm was divided into multiple smaller nodules by a fine fibrous connective tissue stroma. The tubules were lined tiy a single layer of characteristic renal epithelial cells which had a dense, slightly granular cytoplasm (Fig. 3) .
Renal tumors which exhibited a solid pattern had a tendency to contain focal areas of necxosis and hemorrhage. particularly in the larger neoplasms. The cells were frequently arranged in solid sheets but sometimes were divided into packets or cords (Fig. 4 ). The (:ells were generally of uniform size and rarigcd from plump cuboidal to polyhedral (Fis. 5). The cvtoplasm was usually finely gr a n u I a r a n d e 0s i no p h i 1 i c . Mitotic act i v i t y was visible in most tumors but varied between neoplasms.
The metastases in the lung were tubular (Fig. 6) while those in the lymph nodes, spleen, liver, and kidneys tended to form solid sheets. One animal had a Lypical clear cell adenoma in the kidnev in addition to a renal tubular carcinoma.
. most cases, the lymphosarcomas were extensively developed, infiltrating most of the lymph nodes and spleen and metastatic to the liver, kidneys, and lungs. EU/NaN02 and Lead-induced Tumor Latency. Exposure of rats to 26 or 2600 ppm lead did not affect the body weight gain of the animals. For the initial 28 weeks exposure to lead, the animals' mean weight gain was 460,435, and 456 g, respectively, for the 0 , 26, and 2600 ppm lead groups. When presented with the EU/NaNO, diets, however, all animals lost a significant amount of body weight which leveled off after approximately 12 weeks at 75% of their original weights in all three groups.
Deaths began to occur approximately 13 weeks after exposure to the EU/NaNO, diets. Pneumonia accounted for these initial deaths, and the first tumors were not recorded until 22 weeks after EU/NaNO, exposure or 52 weeks of experiment. The latency of tumor development did not appear to be significantly altered by exposure to lead as shown in Table I . The mean survivial time for the EU/NaNO, only group was 28 weeks post exposure to EU/NaN02 or a total of 58 weeks of experiment, while the EU/NaN02 + 26 ppm lead was 33 weeks post EU/NaN02 (63 total weeks). For the EU/NaN02 + 2600 ppm lead group, mean survival time was 32 weeks post ENU. The renal carcinomas which developed in the lead only group were first observed at 72 weeks of exposure to lead (Table I) .
DISCUSSION
The ethyl urea-sodium nitrite system in-. volves exposure of animals to precursors rather than to a direct carcinogenic agent (ethylnitrosourea). The additional factor (ix., lead) to which the organism is exposed may then interact either at the level of endogenous carcinogen formation or at the level of carcinogen action. The precursors themselves are environmental contaminants found in air (lo), water (8), tobacco products (20) , and foods (g), and react in the stomach to form the potent carcinogen, ethylnitrosourea (28) .
Exposure of the fetus in utero to either ENU or the precursors, EU/NaNO, can result in 100% tumors of the nervous system in the progeny after birth. The incidence and distribution of EU/NaNO,-induced neoplasms is highly dependent and predictable upon time of exposure and dose of the chemical(s) (5, 21, 35, 42 ). In the current study, adult rats were exposed to ethyl urea and sodium nitrite. The neoplasms which developed occurred in numerous organs and tissues with only one identified in nervous tissue ( Table  11 ). The predilection and expression of EU/ NaNO, exposure transplacentally is dissimilar to that which occurs in rats exposed as adults. Apparently, the developing nervous tissue is highly susceptible to the carcinogenic activity of EU/NaNO, or its metabolites, while this same tissue in the adult is highly resistant.
A significant feature of these investigations was that administration of 2600 ppm lead for 76 weeks to adult Sprague-Dawley rats resulted in a high incidence (81%) of renal carcinomas. Neoplasms of the kidney did not occur in rats fed ethyl urea, sodium nitrite, and 26 ppm lead for the same period nor in the untreated control rats. Therefore, high concentrations of lead contributed to renal neoplasms in rats but did not appear to be syncarcinogenic with ethyl urea-sodium nitrite-induced neoplasia.
Few reports have incriminated lead (lead acetate) as a carcinogen in laboratory animals. Van Esch and Kroes (44) reported that renal adenomas or carcinomas occurred in 54% of rats fed 10,000 ppm lead for 24 months and 34% in rats fed 1,000 ppm lead for 29 months. In the same year, Boyland et a1 (2) reported that 15 of 16 rats fed 10,000 ppm lead for 320 days developed either renal adenomas or adenocarcinomas. Others have also successfully produced renal neoplasms in rats orally exposed to high levels of lead (15, 29) . In the present study, rats fed lower concentrations of lead for a shorter period developed a high percentage of neoplasms.
Lead also is reported to produce tumors when administered parenterally. Lead phosphate given subcutaneously produced renal tumors in 19 of 29 rats which survived for longer than 10 months (46). Lead administered intramuscularly to rats resulted in neoplasms at both the site of injection and in the kidneys (1 1 ).
Lead appears to enhance the activity of other oncogens. Lead acetate potentiated the oncogenicity of Rauscher leukemia virus in mice (12) . Intratracheal administration of a combination of lead oxide and benzo[a]pyrene resulted in adenomas and adenocarcinomas in the lungs of hamsters when neither alone produced tumors (24) . Lead acetate also enhanced the formation of N-(rl'-fluoro-rl-bi-pheny1)acetamide-induced renal carcinomas by reducing the latent period, increasing the number of tumors per animal, and increasing the percentage of tumor-bearing rats from 70 to 100% (19). Growth of Moloney sarcoma virus-induced tumors was enhanced in ani: mals exposed to lead levels of 310 to 1300 PPm (22) .
It is well-documented that lead compromises the immune response in laboratory animals (25) . For instance, natural killer cell activity was impaired in rat splenocytes treated with lead (7) . Perhaps lead-induced inhibition of the immune system contributes to development of certain types of neoplasia in a primary target organ such as the kidneys. An intact immune response is thought to contribute to the resistance or to regression of many tumors in man and animals (23) .
In this study, lead was not synergistic to the carcinogenic activity of ethyl urea and sodium nitrite. It was originally thought that renal tissue damaged by lead would be predisposed to tumor induction by ethyl ureasodium nitrite. This did not occur since fewer renal tumors developed in the EU/NaNOz lead animals than in animals exposed only to lead. Another environmental pollutant, methylmercury, did potentiate EU/NaN02induced neoplasia when administered transplacenta 11 y (34) .
Lead-induced renal carcinomas are histologically very similar to spontaneously occurring renal carcinomas in humans. Therefore, lead-induced neoplasia in laboratory rats may serve as an animal model of human disease for renal tubular carcinoma. The question remains, however, is lead a carcinogen for humans? In a recent review article on the carcinogenicity of lead (31) , it was concluded that no evidence either of epidemiologic nature or case reports in industrial, agricultural, or community medicine has proven that lead causes cancer in man. Nev-TOXICOLOGIC PATHOLOGY ertheless, since prolonged exposure to lead produces renal carcinomas in laboratory animals, caution should be taken to protect humans from chronic exposure to lead which may be near toxic levels. Further, lead may be a direct carcinogen or as an immunomodulator, may indirectly promote certain carcinogens or combine with other chemicals to induce neoplasia.
